Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | TLSI | Common Stock | 358K | Aug 10, 2023 | By Murphy Family Trust 2012 | F1, F2 | |||||
holding | TLSI | Common Stock | 168K | Aug 10, 2023 | By Sean E Murphy TTEE U/A 2/4/2004 | F1 | |||||
holding | TLSI | Common Stock | 16.6K | Aug 10, 2023 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | TLSI | Employee Stock Option (right to buy) | Aug 10, 2023 | Common Stock | 4.94K | $2.43 | Direct | F1, F4 | ||||||
holding | TLSI | Employee Stock Option (right to buy) | Aug 10, 2023 | Common Stock | 12.4K | $2.43 | Direct | F1, F5 | ||||||
holding | TLSI | Employee Stock Option (right to buy) | Aug 10, 2023 | Common Stock | 124K | $2.43 | Direct | F1, F6 | ||||||
holding | TLSI | Employee Stock Option (right to buy) | Aug 10, 2023 | Common Stock | 31.3K | $10.30 | Direct | F1, F7 |
Id | Content |
---|---|
F1 | The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director and an executive officer of the Issuer. The Reporting Person was appointed as a director and an executive officer of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.). |
F2 | The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012. |
F3 | Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on October 5, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
F4 | The shares subject to this stock option vest in 48 equal monthly installments from October 1, 2021, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
F5 | The shares subject to this stock option vest in 48 equal monthly installments from January 19, 2022, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
F6 | Twenty-five percent of the shares subject to the option vested on July 13, 2023, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
F7 | The shares subject to this stock option vest in 48 equal monthly installments from May 19, 2023, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |